Lilly Agrees To Acquire PCSK9 Base-Editing Partner Verve

 
• By Joseph Haas
  
This is a picture of the Lilly building in San Diego
Lilly acquires base-editing partner Verve and its PCSK9 gene therapy (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Gene Therapies

More from Therapy Areas